Overexpression of GitrL in Recombinant Rabies Virus rLBNSE-GitrL Enhances Innate Immunity by Activating Dendritic Cells and Innate Immune-Related Pathways and Genes
Viruses · 2025
DOI: 10.3390/v17101354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Yufang Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medicine, Dali University, Dali 671000, China. Hauptthemen laut MEDLINE: Rabies virus, Dendritic Cells, Immunity, Innate, Tumor Necrosis Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Planning Project of Yunnan Provincial Department of Science and Technology.
Abstract (Originalsprache)
Rabies, a zoonotic infectious disease causing central nervous system inflammation, remains a threat to public health in regions with limited medical resources. Vaccination effectively reduces rabies incidence and mortality, underscoring the need for vaccines that are cost-effective, immunogenic, protective, and safe. This study constructed a recombinant rabies virus (rRABV)-overexpressing glucocorticoid-induced tumor necrosis factor receptor ligand (GitrL), named rLBNSE-GitrL, using a reverse genetic operating system. rLBNSE-GitrL exhibited similar in vitro phenotypic characteristics and immune safety as the parent RABV (rLBNSE). This recombinant virus stimulated the production of a greater number of activated dendritic cells (DCs) compared to rLBNSE. The enhanced innate immune response induced by rLBNSE-GitrL may be mediated through the activation of innate immune-related signaling pathways, such as the tumor necrosis factor (TNF), and chemokine signaling pathways, and the upregulation of a series of innate immune-related genes, including MMP2, IL-6, CXCL9, TIMP1, IL-17d, and TNF-α. Consequently, rLBNSE-GitrL elicited significantly higher levels of RABV vaccine-induced virus-neutralizing antibodies (VNA), IgG, and IgM compared to rLBNSE as early as 3 days post-immunization (dpi), thereby improving the protective effect in mice. Collectively, the overexpression of GitrL facilitated the induction of early and potent antibody responses following RABV immunization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Basic Medicine, Dali University, Dali 671000, China.
- Dali Nursing Vocational College, Dali 671000, China.
ORCID-Profile: Yaping Liu, Yingying Li
Förderung
- National Natural Science Foundation of China
- Science and Technology Planning Project of Yunnan Provincial Department of Science and Technology
Zitieren
APA
Wang, Y., Xing, X., Xiong, Z., Wang, Y., Liu, Y., & Li, Y. (2025). Overexpression of GitrL in Recombinant Rabies Virus rLBNSE-GitrL Enhances Innate Immunity by Activating Dendritic Cells and Innate Immune-Related Pathways and Genes. Viruses. https://doi.org/10.3390/v17101354
Vancouver
Wang Y, Xing X, Xiong Z, Wang Y, Liu Y, Li Y. Overexpression of GitrL in Recombinant Rabies Virus rLBNSE-GitrL Enhances Innate Immunity by Activating Dendritic Cells and Innate Immune-Related Pathways and Genes. Viruses. 2025. doi:10.3390/v17101354
BibTeX
@article{Wang2025,
author = {Wang, Yufang and Xing, Xiao and Xiong, Zhimin and Wang, Yong and Liu, Yaping and Li, Yingying},
title = {Overexpression of GitrL in Recombinant Rabies Virus rLBNSE-GitrL Enhances Innate Immunity by Activating Dendritic Cells and Innate Immune-Related Pathways and Genes},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17101354}
}
EUVIMED